C.M. Bidwell & Associates’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-61
| Closed | -$1.68K | – | 570 |
|
|
2023
Q3 | $1.68K | Sell |
61
-3,186
| -98% | -$87.9K | ﹤0.01% | 487 |
|
|
2023
Q2 | $97.6K | Sell |
3,247
-935
| -22% | -$28.1K | 0.07% | 244 |
|
|
2023
Q1 | $152K | Buy |
+4,182
| New | +$152K | 0.11% | 158 |
|
|
2022
Q2 | – | Sell |
-2,922
| Closed | -$94K | – | 554 |
|
|
2022
Q1 | $94K | Buy |
2,922
+1,445
| +98% | +$46.5K | 0.06% | 245 |
|
|
2021
Q4 | $43K | Buy |
+1,477
| New | +$43K | 0.03% | 314 |
|
|
2021
Q2 | – | Sell |
-7,725
| Closed | -$202K | – | 618 |
|
|
2021
Q1 | $202K | Buy |
7,725
+7,625
| +7,625% | +$199K | 0.15% | 132 |
|
|
2020
Q4 | $3K | Buy |
+100
| New | +$3K | ﹤0.01% | 450 |
|
|
2020
Q3 | – | Sell |
-2,740
| Closed | -$65K | – | 510 |
|
|
2020
Q2 | $65K | Buy |
+2,740
| New | +$65K | 0.06% | 236 |
|
|
2018
Q3 | – | Sell |
-970
| Closed | -$58K | – | 452 |
|
|
2018
Q2 | $58K | Buy |
+970
| New | +$58K | 0.05% | 237 |
|